This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Letter to the Editor

Increased Lithium Concentrations Reported in Patients Treated With Sulindac

Michael T. Jones and Steven C. Stoner

Published: July 31, 2000

Article Abstract

Letter to the Editor

Sir: Lithium continues to be a primary treatment of choice in bipolar disorder; however, the use of this mood stabilizer requires close monitoring owing to a narrow therapeutic range. Equally important is the close monitoring of adverse drug reactions and toxicity resulting from concomitant medications. A specific association with increased lithium concentrations has been established for nonsteroidal anti-inflammatory drugs (NSAIDs). Several reports in the literature support the idea that concomitant NSAID administration raises lithium concentrations.

Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 61

Quick Links: